CRDF — Cardiff Oncology Share News
0.000.00%
Last trade - 00:00- $70.58m
- $34.93m
- $0.59m
Cardiff Oncology Inc expected to post a loss of 28 cents a share - Earnings Preview
Cardiff Oncology Inc reports results for the quarter ended in September - Earnings Summary
Cardiff Oncology Inc expected to post a loss of 28 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Nucor, Liberty Energy, Micron Technology
U.S. STOCKS ON THE MOVE-SoundHound, Tesla, Energy firms
Cardiff Oncology jumps on positive data from mid-stage studies
Refinitiv Newscasts - U.S. Morning Call: Shutdown looms as US Senate, House take dueling tacks on funding
Brief: Cardiff Oncology Announces Positive Clinical Data In Pancreatic Cancer And Small Cell Lung Cancer
Cardiff Oncology Inc expected to post a loss of 27 cents a share - Earnings Preview
Brief: Cardiff Oncology Reports First-Quarter 2023 Results And Provides Business Update
Cardiff Oncology Inc reports results for the quarter ended in March - Earnings Summary
Cardiff Oncology Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Cardiff Oncology Announces First Patient Dosed In Mid-stage Trial Of Colorectal Cancer Drug
Brief: Cardiff Oncology Inc Confirms It Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Cardiff Oncology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Cardiff Oncology Reports Q4 And Full Year 2022 Results And Provides Business Update
Cardiff Oncology Inc expected to post a loss of 23 cents a share - Earnings Preview
Cardiff Oncology Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Cardiff Oncology Appoints Fairooz Kabbinavar As Chief Medical Officer